Urotensin II(Gillichthys mirabilis reduced) (9CI)(81643-78-9)
- Name: Urotensin II(Gillichthys mirabilis reduced) (9CI)
- Synonyms:1: PN:US20040121343 PAGE: 31 unclaimed sequence; 31: PN: WO0031265 FIGURE: 6unclaimed sequence; 35: PN: WO2004045592 SEQID: 35 unclaimed sequence; 3: PN:US6159700 SEQID: 3 claimed sequence; 6: PN: WO0114888 SEQID: 4 unclaimedsequence; 77: PN: US20090175821 SEQID: 99 claimed protein; 7: PN: US20050255484SEQID: 7 unclaimed sequence; 7: PN: WO2004037863 SEQID: 6 claimed sequence; 96:PN: WO0069900 SEQID: 99 unclaimed sequence; L-Valine,N-[N-[N-[N2-[N-[N-[N-[N-[N-[N-(N-L-alanylglycyl)-L-threonyl]-L-alanyl]-L-a-aspartyl]-L-cysteinyl]-L-phenylalanyl]-L-tryptophyl]-L-lysyl]-L-tyrosyl]-L-cysteinyl]-
- Molecular Formula:C62H86 N14 O17 S2
- Molecular Weight:1363.58
- CAS Registry Number:81643-78-9
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 62295-16-3/1-ETHYL-3-HYDRAZONO-1,3-DIHYDRO-INDOL-2-ONE
- 70693-13-9/Safflower oil, polymer with pentaerythritol, phthalic anhydride andvinyltoluene
- 8049-97-6/MELANIN
- 127943-74-2/(+/-)-2,3-Dihydro-6-methoxy-3-(((methylsulfonyl)oxy)methyl)-1H-indole- 1-carboxylic acid 1,1-dimethylethyl ester
- 113609-67-9/Akkotrol 623 (9CI)
- 133136-54-6/N-methyl-2-aminoethylphosphonylglucosylceramide
- 81820-09-9/N-[4-(2-{(2E)-2-[5-methyl-1-(morpholin-4-ylmethyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]hydrazinyl}-2-oxoethoxy)phenyl]acetamide
- 102367-10-2/N-benzyl-N-(4-methoxybenzyl)-2-pyrrolidin-1-ylethanamine dihydrochloride
- 3917-59-7/[1R-(1alpha,3alpha,5alpha)]-6,6-dimethyl-2-methylenebicyclo[3.1.1]heptan-3-ol
- 153965-59-4/Isocyanic acid, polymethylenepolyphenylene ester, polymer with alpha-hydro-omega-hydroxypoly(oxy(methyl-1,2-ethanediyl)) and 1,1-methylenebis(isocyanatobenzene)
- 55400-67-4/3-(trifluoromethyl)phenyl 3-(trifluoromethyl)benzenesulfonate
- 7251-53-8/ethyl 3-hydroxy-1H-pyrazole-4-carboxylate
- 100482-76-6/N-methyl-N-(2-phenoxyphenoxy)butan-1-amine hydrochloride
- 39379-39-0/Cuprate(3-),[2-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-5-(hydroxy-kO)-6-[2-[2-(hydroxy-kO)-5-sulfophenyl]diazenyl-kN1]-1,7-naphthalenedisulfonato(5-)]-,hydrogen (1:3)
- 73484-57-8/5-(4-ethoxy-3,5-dimethoxyphenyl)-3-({[3-(trifluoromethyl)phenyl]amino}methyl)-1,3,4-oxadiazol-2(3H)-one
- 80812-94-8/2-{4-methyl-1-[2-(piperidin-1-yl)ethyl]pyridin-2(1H)-ylidene}-1H-indene-1,3(2H)-dione
- 72929-00-1/Hydroxyethyl methacrylate, octadecyl methacrylate, dimethylaminoethyl methacrylate polymer
- 143909-01-7/1,2-Cyclohexanedicarboxamide,N,N,N',N'-tetracyclohexyl-, (1R,2S)-rel- (9CI)
- 81643-78-9/Urotensin II(Gillichthys mirabilis reduced) (9CI)
- 37250-20-7/Dehydrogenase, D-malate(decarboxylating)
- 5614-44-8/N-(3-chloro-4-methylphenyl)-N-[(4-chlorophenyl)sulfonyl]acetamide
- 99363-36-7/N-{3-[({3-[(3-{[2-(2-ethylbutyl)heptyl]oxy}propyl)amino]propyl}amino)methyl]-2-methyl-5-nonylbenzyl}hexane-1,6-diamine
- 68092-63-7/Ethanaminium, 2-hydroxy-N-(2-hydroxyethyl)-N,N-dimethyl-, methyl sulfate (salt), polymer with alpha-hydro-omega-hydroxypoly(oxy(methyl-1,2-ethanediyl)) and 1,1-methylenebis(isocyanatocyclohexane)
- 96508-13-3/Amines,C12-14-tert-alkyl,4-[2-(5-cyano-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl)diazenyl]-1,3-benzenedisulfonates(2:1)
- 144634-02-6/3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(3,5-diMethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-8-(trifluoroMethyl)-
- 82322-37-0/Poly(oxy-1,2-ethanediyl),a,a'-[[[3-(tridecyloxy)propyl]imino]di-2,1-ethanediyl]bis[w-hydroxy-
- 25322-01-4/Propane, nitro-
- 62681-99-6/2,5-bis(3-fluorophenyl)-1,3,4-oxadiazole
- 5463-59-2/3-carbamoyl-1-propylpyridinium
- 74275-81-3/2-{bis[2-(nonanoyloxy)ethyl]amino}-2-oxoethyl nonanoate